Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 65 - 72 of 11616 results
Impending SECURE Act 2.0 Auto-Enrollment Requirement Prompts These Questions
November 19, 2024| News
Just Around the Corner, Iowa’s Consumer Privacy Law Taking Effect
November 19, 2024| Blog| Viewpoint
2025 Private Equity Trends Outlook
November 19, 2024| Blog| Viewpoint
Federal Court Strikes Down the U.S. Department of Labor’s Overtime Rule
November 18, 2024| News
President Trump Redux – Potential Impacts on the Immigration Landscape
November 15, 2024| Alert| Viewpoint
Despite Vaccine Spotlight, RFK Jr. A Health Policy 'Unknown'
November 15, 2024| News
Now 'Back to Stability,' Mass. US Atty Office Set to Ramp Up
November 15, 2024| News
Structuring Your Company for Cross-Border Opportunities in Life Sciences
November 14, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.